Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours

BJU International

Volumn 113, Issue 1, 2014, Pages 51-55

  Ma, Yunbo ^a   Bedir, Selahattin ^b   Cadeddu, Jeffrey A ^b   Gahan, Jeffrey C ^b  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

nephron sparing surgery; oncological outcomes; radiofrequency ablation; renal tumour

Indexed keywords

ACALCULOUS CHOLECYSTITIS; ADULT; AMERICAN SOCIETY OF ANESTHESIOLOGISTS SYMPTOM SCORE; ARTICLE; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; TUMOR RECURRENCE; TUMOR VOLUME;

NEPHRON-SPARING SURGERY; ONCOLOGICAL OUTCOMES; RADIOFREQUENCY ABLATION; RENAL TUMOUR;

CARCINOMA, RENAL CELL; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; UNITED STATES;

EID: 84890466198     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12366     Document Type: Article

References (21)

1. Chen DY, Uzzo RG,. Evaluation and management of the renal mass. Med Clin North Am 2011; 95: 179-189
2. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008; 179: 468-471; discussion 472-3
3. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7: 735-740
4. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182: 1271-1279
5. Fergany AF, Hafez KS, Novick AC,. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000; 163: 442-445
6. Pasticier G, Timsit MO, Badet L, et al. Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol 2006; 49: 485-490
7. Stern JM, Gupta A, Raman JD, et al. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome. BJU Int 2009; 104: 786-789
8. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl. 1): S1-266
9. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV,. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179: 75-79; discussion 79-80
10. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ,. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003; 180: 1503-1508
11. McDougal WS, Gervais DA, McGovern FJ, Mueller PR,. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 2005; 174: 61-63
12. Whitson JM, Harris CR, Meng MV,. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses. BJU Int 2012; 110: 1438-1443; discussion 43
13. Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA,. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 2012; 61: 1156-1161
14. Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA,. Long-term oncologic outcomes after radiofrequency ablation for t1 renal cell carcinoma. Eur Urol 2013; 63: 486-492
15. Best SL, Park SK, Youssef RF, et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol 2012; 187 (4): 1183-1189
16. Hiraoka K, Kawauchi A, Nakamura T, Soh J, Mikami K, Miki T,. Radiofrequency ablation for renal tumors: our experience. Int J Urol 2009; 16: 869-873
17. Zagoria RJ, Hawkins AD, Clark PE, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004; 183: 201-207
18. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
19. Wolters U, Wolf T, Stutzer H, Schroder T,. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996; 77: 217-222
20. Ha YS, Park YH, Kang SH, et al. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study. Clin Genitourin Cancer 2013; 11 (1): 51-55
21. Brookman-May S, May M, Shariat SF, et al. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Eur Urol 2013; 64: 472-477